Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2021-05-24 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text is extremely short (58 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient filings.
2021-05-24 English
Press Release
Regulatory Filings
2021-05-24 English
Updates
Legal Proceedings Report Classification · 100% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) informing about a legal suit filed by Panacea Biotec Limited against Sanofi Healthcare India Private Limited. The content focuses on the details of the lawsuit, patent infringement claims, and related legal proceedings. There are no financial statements, earnings data, or management discussions. The document is clearly a legal update regarding ongoing litigation involving the company. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 4733 characters, which is sufficient to provide substantive information about the legal matter rather than a brief announcement.
2021-05-17 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2021-05-07 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification on the movement in the company's stock price. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The letter states that the company has made all necessary disclosures and that there is no pending information that could affect the stock price or volume. The document is short (1545 characters) and serves as a regulatory communication or clarification rather than a financial report or announcement of a report. It does not contain financial data, earnings, management discussion, or any report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance communications that do not fit other categories.
2021-04-29 English
Annual Disclosure
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, financial data, or any specific information. It appears to be a placeholder or an empty document with no report or announcement details. Given the lack of content, it cannot be classified as any specific report type. According to the rules, such minimal or empty documents fall under the fallback category of Regulatory Filings (RNS).
2021-04-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.